“Glucose, Urea, and Creatinine Laboratory Tests in People Starting Antiretroviral Therapy With Dolutegravir or Efavirenz: A Cohort Study in Belo Horizonte, Brazil”. 2022. Research, Society and Development 11 (5): e43711528541. https://doi.org/10.33448/rsd-v11i5.28541.